Bottom-line per provider
- • GoodRx Care — cheapest brand-only access ($39 sub + $199 intro). Trap: maintenance dose = $1,389/mo cash.
- • Ro Body — strongest brand-only program ($145 fee, labs included). Best fit: commercial insurance + structured plan.
- • Henry Meds — compounded semaglutide/tirzepatide $199-299/mo. FDA enforcement risk accepted.
- • Eden — lowest cash entry ($99/mo starter). HIGH FDA enforcement risk. Best fit: lowest possible cash, risk-tolerant.
Comparison matrix
| Provider | Type | Telehealth fee | Starter price | Maintenance | Our score |
|---|---|---|---|---|---|
| GoodRx Care | FDA brand | $39/mo sub | $199 (intro) | $1,389/mo cash | 7.5/10 |
| Ro Body | FDA brand | $145 program | Insurance OR list | Insurance OR list | 8.7/10 |
| Henry Meds | Compounded | Bundled | ~$199/mo | ~$299/mo | 6.5/10 |
| Eden | Compounded | Bundled | ~$99/mo | ~$296/mo | 6.8/10 |
Prices as published 2026-06-05. Verify directly with each provider before deciding. Compounded pricing varies by dose mg/mL formulation.
Head-to-head deep dive
1. GoodRx Care vs Ro Body (brand-only matchup)
Both prescribe FDA-approved Wegovy and Ozempic — same drug, same FDA safety oversight. Differences:
- Telehealth fee: GoodRx Care $39/mo subscription vs Ro $145 one-time enrollment + ongoing free check-ins
- Care model: GoodRx async-only (text), Ro async + video onboarding + optional labs
- Drug pricing: GoodRx $199 intro covers ONLY 0.25/0.5 mg doses. Ro relies on insurance OR cash list price for both starter and maintenance
- Best fit: If insurance covers Wegovy → Ro wins on structure + labs. If insurance won\'t cover and you\'re cash-paying on starter doses → GoodRx wins on price
2. Henry Meds vs Eden (compounded matchup)
Both compound semaglutide and tirzepatide via 503A pharmacies, both carry FDA enforcement risk, both async-first. Differences:
- Entry price: Eden $99/mo starter beats Henry $199. Eden\'s low entry uses lower-mg starter formulations.
- Maintenance: Henry $299/mo vs Eden $296/mo — essentially tied at clinical doses
- Trustpilot signals: Eden higher review volume (1,800+) vs Henry (~800). Both ~4.2-4.4 average.
- FDA warning letter status: Neither has received direct warning as of Jun 2026, but both operate in the same enforcement crosshair after March 2026 actions
- Best fit: Eden if absolute lowest entry matters. Henry if slightly larger brand history + slightly easier signup matters.
3. Brand vs compounded (FDA risk axis)
The cleanest decision axis. Brand-name (GoodRx Care, Ro) = FDA-reviewed finished product, manufacturer-controlled dose accuracy, no enforcement risk. Compounded (Henry, Eden) = pharmacy-mixed, not FDA-reviewed as finished product, ~50-70% cash savings vs brand list, ongoing legal/ enforcement uncertainty post April 2025 (semaglutide) / March 2025 (tirzepatide) compounding sunsets.
FDA compliance note
Compounded GLP-1 medications are NOT FDA-approved as finished products. They\'re mixed by licensed compounding pharmacies under section 503A of the FD&C Act. FDA enforcement against telehealth firms increased in March 2026; legal status may change quickly. Cost savings carry real regulatory risk. Discuss with your prescriber, not just with telehealth marketing pages.
Decision tree — which fits you
Pick GoodRx Care if…
- ✓ Insurance covers Wegovy/Ozempic
- ✓ OR willing to stay on starter doses long-term
- ✓ Want cheapest telehealth wrapper ($39/mo)
- ✓ Don\'t need labs or coaching
Pick Ro Body if…
- ✓ Insurance covers brand GLP-1
- ✓ Want structured program + labs included
- ✓ Need video onboarding for complex history
- ✓ Multi-drug optionality (Mounjaro/Zepbound too)
Pick Henry Meds if…
- ✓ Cash-pay, no insurance coverage for brand
- ✓ Accept compounded FDA enforcement risk
- ✓ Want established compounded brand
- ✓ Mid-tier cash price ($199-299/mo) OK
Pick Eden if…
- ✓ Absolute lowest entry price priority ($99 starter)
- ✓ Accept high compounded enforcement risk
- ✓ Comfortable with newer-brand telehealth signup
- ✓ Verify state-served list before commit
Hidden tradeoffs none advertise loudly
- GoodRx Care: Conflict of interest — GoodRx earns coupon affiliate revenue when readers fill scripts at any pharmacy, including from competing telehealth providers. Their positioning vs alternatives won\'t always be transparent.
- Ro Body: Insurance-first model means cash payers see list-price stickers. Without commercial insurance, Ro\'s value drops vs cheaper alternatives.
- Henry Meds: Recent business model pivot in 2026 vs early launches. Some legacy users report changes to dose schedules + delivery timelines per Trustpilot.
- Eden: Lowest-tier brand recognition — newer player, less longitudinal data on retention. Cancellation friction reportedly higher than competitors per community forums.
Frequently asked questions
Which is cheapest cash overall?
Eden ($99-296/mo) and Henry Meds ($199-299/mo) win on raw cash math because they use compounded semaglutide/tirzepatide — pharmacy-mixed, not FDA-approved as finished products. GoodRx Care ($238/mo starter, $1,389/mo maintenance) is cheapest brand-only up to titration. Ro requires insurance to be competitive on cost; cash patients pay near-list price.
Which is safest from FDA enforcement?
GoodRx Care and Ro Body — both prescribe only FDA-approved brand-name medications (Wegovy, Ozempic, Zepbound, Mounjaro). Compounded providers (Henry, Eden) carry ongoing FDA enforcement risk per March 2026 warning letters to 30+ telehealth firms. Compounding semaglutide ended April 2025, tirzepatide March 2025 — providers operating in 503A "patient-specific shortage" loophole face increasing scrutiny.
Why is GoodRx Care intro pricing only on starter doses?
The $199/mo intro covers 0.25 mg and 0.5 mg Wegovy/Ozempic only. These are the titration doses you ramp up from in weeks 1-12. By month 4-5, most patients reach 1.0 mg, then 1.7 mg, then 2.4 mg maintenance — and the intro disappears. Cash cost on maintenance: ~$1,350/mo list price + $39 telehealth sub. Verify your target dose before signing up.
Is Eden the cheapest because it's worse?
Not worse in terms of provider licensing or fulfillment infrastructure. Cheaper because compounded semaglutide skips FDA approval costs ($1B+) and patent royalties Novo Nordisk charges. Tradeoffs: no FDA safety/efficacy review on the finished product; injection site reactions and dose-accuracy variance reported in community forums; legal status in flux per ongoing FDA enforcement.
Which gets you results fastest?
All four ship Rx within 3-7 days if intake submitted promptly. GoodRx Care + Eden + Henry Meds use async text consults (intake reviewed in hours). Ro Body schedules a brief video onboarding + may request labs first (adds 7-10 days). Time-to-first-shipment: Eden and GoodRx Care fastest, Ro slowest.
Can I switch between them mid-treatment?
Yes — none of the four lock you in. Cancellation is account-level (1-2 clicks per Trustpilot reports). Be aware: switching from compounded to brand requires new provider intake and starting over with FDA-approved dose titration; switching from brand to compounded may require breaking insurance fill cycle. Plan switch at end of current month's supply.
Bottom line
There\'s no universal winner across these four — choice depends entirely on insurance status and compounded-risk tolerance. Brand-only with insurance: Ro Body. Brand-only cash on starter doses: GoodRx Care. Cash-pay willing to accept compounding risk: Eden (lowest entry) or Henry Meds (more established). All four ship in 3-7 days, all four async-first, all four cancellable account-level. The real decision filter — read your insurance EOB, check your target maintenance dose, and decide if compounded FDA risk is acceptable to you.
Compare all 13 GLP-1 providers side-by-side
Filter by insurance, drug, state, cash price. 60-second match.
Sources
- GoodRx Care service page — pricing reference fetched 2026-06-05.
- Ro Body Program pricing — $145 enrollment fee reference.
- Henry Meds weight loss page — compounded semaglutide pricing.
- Eden weight loss — compounded GLP-1 pricing.
- FDA semaglutide compounding guidance — March 2026 enforcement context.
Editorial only — not medical advice. Discuss medication decisions with your prescribing clinician. All pricing accurate as of 2026-06-05; verify directly with each provider before signing up.